Atlas Trials

Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis

Clinical trial NCT01124149 · COMPLETED

Trial details

NCT number
NCT01124149
Sponsor
Shire
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2010-06-29
Primary completion
2012-12-07
Enrollment
759

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.